文献速递头颈外科咽喉与嗓音

口咽癌患者胃造瘘使用部分由吞咽功能驱动

Gastrostomy Utilization by Oropharyngeal Cancer Patients Is Partially Driven by Swallowing Function.
PubMed 文献 · Laryngoscope · 2019-09-30

结果显示治疗前后DIGEST评分与T分期相关,且治疗期间吞咽功能恶化,但DIGEST和MDADI评分与经皮透视引导胃造瘘管(PFG)使用无关。结论认为客观吞咽功能不能预测PFG使用,制定PFG放置算法需额外指标。

要点

  • 放疗前DIGEST和MDADI可识别吞咽不安全或严重低效的患者。
  • 治疗前后DIGEST评分与T分期相关,治疗期间吞咽功能显著恶化。
  • DIGEST和MDADI评分与PFG使用无显著关联,PFG算法需更多指标。

核心结论

  • 放疗前DIGEST和MDADI有助于识别吞咽不安全或严重低效的口咽癌患者。
  • 客观测量的吞咽功能与PFG使用无关,PFG放置算法需额外输入指标。

研究设计与样本

  • 放疗前和放疗结束时采用MBSS和DIGEST评估吞咽功能,部分患者使用MDADI评估。
  • 证据等级为4级,发表于Laryngoscope 2020;130:2153-2159。

主要发现

  • 患者100%为男性,85.4%为白人,85.4%为p16阳性,平均年龄65.7岁。
  • 70.7%患者(n=29)放置PFG,63.4%(n=26)使用PFG。
  • 治疗前后DIGEST评分与T分期相关(t=-2.9, p=.001;t=-2.7, p=.01)。
  • 治疗期间DIGEST评分平均变化0.46(t=-2.7, p=.01),提示吞咽功能恶化。
  • DIGEST和MDADI评分与PFG使用一般无关联;两者在治疗前显著相关,治疗后不相关。

临床怎么用

  • 放疗前DIGEST和MDADI可用于识别吞咽功能不安全或严重低效的患者。
  • 不应仅凭DIGEST或MDADI评分决定PFG放置,需结合其他指标制定算法。

局限性

  • 证据等级为4级,属于回顾性或观察性研究设计。
  • 仅部分患者完成MDADI评估,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Oropharyngeal squamous cell carcinoma (OPSCC) incidence is rapidly increasing, as are survival rates, in large part due to the human papillomavirus (HPV). Treatment intensity, however, has remained unchanged, making treatment-related toxicity (i.e., dysphagia) a critical problem for an increasing number of patients. The primary objective of this study was to determine whether pretreatment objective swallowing measures can predict percutaneous fluoroscopic guided gastrostomy tube (PFG) utilization during OPSCC treatment. METHODS: Forty-one newly diagnosed OPSCC patients treated with radiation underwent evaluation of swallow function with modified barium swallow study (MBSS) prior to and at completion of radiation treatment using the Dynamic Imaging Grade of Swallowing Toxicity (DIGEST); a subset of patients were evaluated using the MD Anderson Dysphagia Inventory (MDADI). RESULTS: Patients were male (100%), primarily Caucasian (85.4%) and p16 positive (85.4%) with mean age of 65.7 years. PFG were placed in 70.7% patients (n = 29) and used by 63.4% (n = 26). Pre- and post-treatment DIGEST scores were associated with T-classification (t = -2.9, p = .001, t = -2.7, p = .01) and indicated deteriorating swallow function during treatment (mean change = 0.46 [t = -2.7, p = .01]). DIGEST and MDADI scores were generally not associated with patient PFG utilization. DIGEST and MDADI scores were significantly correlated prior to, but not following completion of treatment. CONCLUSION: Pre-treatment DIGEST and patient reported swallowing outcomes (MDADI) can be useful in identifying patients with unsafe and/or grossly inefficient swallowing function. However, objectively measured swallow function was not associated with PFG utilization. Development of PFG placement algorithms (reactive vs. prophylactic) therefore require additional inputs/metrics. LEVEL OF EVIDENCE: 4 Laryngoscope, 130:2153-2159, 2020.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Chhabria K, Kansara S, Badr H, et al. Gastrostomy Utilization by Oropharyngeal Cancer Patients Is Partially Driven by Swallowing Function. Laryngoscope. 2019. PMID: 31566749. doi:10.1002/lary.28312

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。